SETDB1
SETDB1 (SET domain bifurcated histone lysine methyltransferase 1, also known as ESET, KMT1E, KG1T, KIAA0067 and TDRD21) is a histone-lysine methyltransferase that regulates histone methylation, gene silencing and transcriptional repression. It belongs to the Suvar3-9 subfamily of histone-lysine methyltransferases. Browse Assay Genie's current range of SETDB1 research reagents below, or read on for the biology behind the target.
SETDB1 is a histone methyltransferase. According to the NCBI Gene summary, it regulates histone methylation, gene silencing and transcriptional repression. By modifying lysine residues on histones, enzymes of this type alter chromatin state and so influence whether genes are expressed, which makes SETDB1 a useful focus for studies of epigenetic regulation and transcriptional control.
The SETDB1 protein is classed in the class V-like SAM-binding methyltransferase superfamily and the Suvar3-9 subfamily of the histone-lysine methyltransferase family. HGNC places the SETDB1 gene in several groups: histone lysine methyltransferases, SET domain containing, Tudor domain containing and methyl-CpG binding domain containing proteins. UniProt records its subcellular locations as the nucleus, cytoplasm and chromosome. Alternatively spliced transcript variants of the gene have been described, so isoform context is worth considering when designing experiments. The mouse ortholog is Setdb1.
The name reflects the bifurcated SET domain, and the gene has previously been listed as SET domain, bifurcated 1. Other symbols in use include ESET, KMT1E, KG1T, KIAA0067 and TDRD21. In disease research, the NCBI Gene summary notes that SETDB1 has been identified as a target for treatment in Huntington disease, because gene silencing and transcription dysfunction are thought to contribute to the pathogenesis of that condition.
SETDB1 regulates histone methylation, making it a central enzyme for studying how lysine methylation shapes chromatin and gene expression.
The enzyme is implicated in gene silencing and transcriptional repression, so it is widely used to probe repressive regulatory mechanisms.
SETDB1 has been identified as a treatment target in Huntington disease, where gene silencing and transcription dysfunction are thought to play a role.
As a Suvar3-9 subfamily member with SET, Tudor and methyl-CpG binding domain classifications, SETDB1 supports comparative work on histone lysine methyltransferases.
SETDB1 is a histone methyltransferase that regulates histone methylation, gene silencing and transcriptional repression. It belongs to the Suvar3-9 subfamily of histone-lysine methyltransferases and is assigned EC 2.1.1.366. It is found in the nucleus, cytoplasm and on chromosomes.
SETDB1 is also called ESET, KMT1E, KG1T, KIAA0067 and TDRD21. Earlier gene names were SET domain, bifurcated 1 and SET domain bifurcated 1. NCBI reports that alternatively spliced transcript variants of the gene have been described.
NCBI Gene notes SETDB1 as a target for treatment in Huntington disease, since gene silencing and transcription dysfunction likely contribute to its pathogenesis. The mouse ortholog is Setdb1. Check the datasheet of any product for its validated reactivity.
Other histone lysine methyltransferases, epigenetic regulators and Huntington disease-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15047; product specifications from Assay Genie datasheets.